Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 6, 2019
Previous Article Next Article

Vitamin B12 transports modified RNA into E. coli and S. Typhimurium cells

Author affiliations

Abstract

Specifically designed, antisense oligonucleotides are promising candidates for antibacterial drugs. They suppress the correct expression of bacterial genes by complementary binding to essential sequences of bacterial DNA or RNA. The main obstacle in fully utilizing their potential as therapeutic agents comes from the fact that bacteria do not uptake oligonucleotides from their environment. Herein, we report that vitamin B12 can transport oligonucleotides into Escherichia coli and Salmonella typhimurium cells. 5′-Aminocobalamin with an alkyne linker and azide-modified oligonucleotides enabled the synthesis of vitamin B12–2′OMeRNA conjugates using an efficient “click” methodology. Inhibition of protein expression in E. coli and S. Typhimurium cells indicates an unprecedented transport of 2′OMeRNA oligomers into bacterial cells via the vitamin B12 delivery pathway.

Graphical abstract: Vitamin B12 transports modified RNA into E. coli and S. Typhimurium cells

Back to tab navigation

Supplementary files

Publication details

The article was received on 25 Jun 2018, accepted on 19 Nov 2018 and first published on 19 Nov 2018


Article type: Communication
DOI: 10.1039/C8CC05064C
Citation: Chem. Commun., 2019,55, 763-766

  •   Request permissions

    Vitamin B12 transports modified RNA into E. coli and S. Typhimurium cells

    M. Giedyk, A. Jackowska, M. Równicki, M. Kolanowska, J. Trylska and D. Gryko, Chem. Commun., 2019, 55, 763
    DOI: 10.1039/C8CC05064C

Search articles by author

Spotlight

Advertisements